232 related articles for article (PubMed ID: 10450506)
1. Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice.
Hong S; Scherer DC; Singh N; Mendiratta SK; Serizawa I; Koezuka Y; Van Kaer L
Immunol Rev; 1999 Jun; 169():31-44. PubMed ID: 10450506
[TBL] [Abstract][Full Text] [Related]
2. Regulation of immune responses by CD1d-restricted natural killer T cells.
Van Kaer L
Immunol Res; 2004; 30(2):139-53. PubMed ID: 15477656
[TBL] [Abstract][Full Text] [Related]
3. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
[TBL] [Abstract][Full Text] [Related]
4. Phage display-derived recombinant antibodies with TCR-like specificity against alpha-galactosylceramide and its analogues in complex with human CD1d molecules.
Denkberg G; Stronge VS; Zahavi E; Pittoni P; Oren R; Shepherd D; Salio M; McCarthy C; Illarionov PA; van der Merwe A; Besra GS; Dellabona P; Casorati G; Cerundolo V; Reiter Y
Eur J Immunol; 2008 Mar; 38(3):829-40. PubMed ID: 18253930
[TBL] [Abstract][Full Text] [Related]
5. Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide.
Jahng A; Maricic I; Aguilera C; Cardell S; Halder RC; Kumar V
J Exp Med; 2004 Apr; 199(7):947-57. PubMed ID: 15051763
[TBL] [Abstract][Full Text] [Related]
6. Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes.
Burdin N; Brossay L; Koezuka Y; Smiley ST; Grusby MJ; Gui M; Taniguchi M; Hayakawa K; Kronenberg M
J Immunol; 1998 Oct; 161(7):3271-81. PubMed ID: 9759842
[TBL] [Abstract][Full Text] [Related]
7. Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype.
Singh N; Hong S; Scherer DC; Serizawa I; Burdin N; Kronenberg M; Koezuka Y; Van Kaer L
J Immunol; 1999 Sep; 163(5):2373-7. PubMed ID: 10452969
[TBL] [Abstract][Full Text] [Related]
8. Delineation of a CD1d-restricted antigen presentation pathway associated with human and mouse intestinal epithelial cells.
van de Wal Y; Corazza N; Allez M; Mayer LF; Iijima H; Ryan M; Cornwall S; Kaiserlian D; Hershberg R; Koezuka Y; Colgan SP; Blumberg RS
Gastroenterology; 2003 May; 124(5):1420-31. PubMed ID: 12730881
[TBL] [Abstract][Full Text] [Related]
9. Regulation of CD1d expression by murine tumor cells: escape from immunosurveillance or alternate target molecules?
Fiedler T; Walter W; Reichert TE; Maeurer MJ
Int J Cancer; 2002 Mar; 98(3):389-97. PubMed ID: 11920590
[TBL] [Abstract][Full Text] [Related]
10. Presentation of alpha-galactosylceramide by murine CD1d to natural killer T cells is facilitated by plasma membrane glycolipid rafts.
Lang GA; Maltsev SD; Besra GS; Lang ML
Immunology; 2004 Jul; 112(3):386-96. PubMed ID: 15196206
[TBL] [Abstract][Full Text] [Related]
11. Expression of human CD1d molecules protects target cells from NK cell-mediated cytolysis.
Campos-Martín Y; Gómez del Moral M; Gozalbo-López B; Suela J; Martínez-Naves E
J Immunol; 2004 Jun; 172(12):7297-305. PubMed ID: 15187105
[TBL] [Abstract][Full Text] [Related]
12. Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice.
Saubermann LJ; Beck P; De Jong YP; Pitman RS; Ryan MS; Kim HS; Exley M; Snapper S; Balk SP; Hagen SJ; Kanauchi O; Motoki K; Sakai T; Terhorst C; Koezuka Y; Podolsky DK; Blumberg RS
Gastroenterology; 2000 Jul; 119(1):119-28. PubMed ID: 10889161
[TBL] [Abstract][Full Text] [Related]
13. Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis.
Burdin N; Brossay L; Kronenberg M
Eur J Immunol; 1999 Jun; 29(6):2014-25. PubMed ID: 10382765
[TBL] [Abstract][Full Text] [Related]
14. The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice.
Hong S; Wilson MT; Serizawa I; Wu L; Singh N; Naidenko OV; Miura T; Haba T; Scherer DC; Wei J; Kronenberg M; Koezuka Y; Van Kaer L
Nat Med; 2001 Sep; 7(9):1052-6. PubMed ID: 11533710
[TBL] [Abstract][Full Text] [Related]
15. Regulation by Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 of alpha-galactosylceramide-induced antimetastatic activity and Th1 and Th2 responses of NKT cells.
Okajo J; Kaneko Y; Murata Y; Tomizawa T; Okuzawa C; Saito Y; Kaneko Y; Ishikawa-Sekigami T; Okazawa H; Ohnishi H; Matozaki T; Nojima Y
J Immunol; 2007 May; 178(10):6164-72. PubMed ID: 17475843
[TBL] [Abstract][Full Text] [Related]
16. Antigen presentation by CD1d contributes to the amplification of Th2 responses to Schistosoma mansoni glycoconjugates in mice.
Faveeuw C; Angeli V; Fontaine J; Maliszewski C; Capron A; Van Kaer L; Moser M; Capron M; Trottein F
J Immunol; 2002 Jul; 169(2):906-12. PubMed ID: 12097395
[TBL] [Abstract][Full Text] [Related]
17. Lipid Antigen Presentation by CD1b and CD1d in Lysosomal Storage Disease Patients.
Pereira CS; Pérez-Cabezas B; Ribeiro H; Maia ML; Cardoso MT; Dias AF; Azevedo O; Ferreira MF; Garcia P; Rodrigues E; Castro-Chaves P; Martins E; Aguiar P; Pineda M; Amraoui Y; Fecarotta S; Leão-Teles E; Deng S; Savage PB; Macedo MF
Front Immunol; 2019; 10():1264. PubMed ID: 31214199
[TBL] [Abstract][Full Text] [Related]
18. Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules.
Naidenko OV; Maher JK; Ernst WA; Sakai T; Modlin RL; Kronenberg M
J Exp Med; 1999 Oct; 190(8):1069-80. PubMed ID: 10523605
[TBL] [Abstract][Full Text] [Related]
19. CD1d-mediated antigen presentation to natural killer T (NKT) cells.
Brutkiewicz RR; Lin Y; Cho S; Hwang YK; Sriram V; Roberts TJ
Crit Rev Immunol; 2003; 23(5-6):403-19. PubMed ID: 15030309
[TBL] [Abstract][Full Text] [Related]
20. Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells.
Kang SJ; Cresswell P
Nat Immunol; 2004 Feb; 5(2):175-81. PubMed ID: 14716312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
